BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33185168)

  • 1. Bronchoalveolar Lavage in Systemic Sclerosis Patients: A Systematic Review.
    da Silva SO; da Paz AS; Farias IMVC; Moreira DS; Ribeiro MAF; Alves TSGN; Lemos ACM; Santiago MB
    Curr Rheumatol Rev; 2021; 17(2):176-183. PubMed ID: 33185168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
    Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
    Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
    Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
    Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
    Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
    Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
    De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
    Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review.
    Orlandi M; Meliante LA; Damiani A; Tofani L; Bruni C; Guiducci S; Matucci-Cerinic M; Bellando-Randone S; Tomassetti S
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
    Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease.
    Yilmaz N; Abul Y; Bicakcigil M; Golabi P; Celikel C; Karakurt S; Yavuz S
    Rheumatol Int; 2012 Jul; 32(7):1921-5. PubMed ID: 21448645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in systemic sclerosis.
    Kaloudi O; Miniati I; Alari S; Matucci-Cerinic M
    Intern Emerg Med; 2007 Dec; 2(4):250-5. PubMed ID: 18172592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis with other idiopathic and secondary interstitial lung diseases.
    Rossi G; Andreani A; Morandi P; Marchioni A; Corradini P; Cappiello G; Bortolotti M; Qosja A; Manzini C; Ferri C; Richeldi L; Cavazza A
    Am J Clin Pathol; 2008 Dec; 130(6):927-33. PubMed ID: 19019770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial lung disease of systemic sclerosis.
    Silver RM
    Int Rev Immunol; 1995; 12(2-4):281-91. PubMed ID: 7650424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
    Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
    Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
    Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
    Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.
    Bolster MB; Ludwicka A; Sutherland SE; Strange C; Silver RM
    Arthritis Rheum; 1997 Apr; 40(4):743-51. PubMed ID: 9125259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.